These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 9839511)

  • 1. Lest we abandon digital rectal examination as a screening test for prostate cancer.
    Basler JW; Thompson IM
    J Natl Cancer Inst; 1998 Dec; 90(23):1761-3. PubMed ID: 9839511
    [No Abstract]   [Full Text] [Related]  

  • 2. Re: Lest we abandon digital rectal examination as a screening test for prostate cancer.
    Schröder FH
    J Natl Cancer Inst; 1999 Aug; 91(15):1331-2. PubMed ID: 10433626
    [No Abstract]   [Full Text] [Related]  

  • 3. Evaluation of the digital rectal examination as a screening test for prostate cancer. Rotterdam section of the European Randomized Study of Screening for Prostate Cancer.
    Schröder FH; van der Maas P; Beemsterboer P; Kruger AB; Hoedemaeker R; Rietbergen J; Kranse R
    J Natl Cancer Inst; 1998 Dec; 90(23):1817-23. PubMed ID: 9839522
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Update on urology--prostate cancer. Screening for prostate cancer: an European view.
    de Silva FC
    Eur J Surg Oncol; 1996 Apr; 22(2):189-91, 196. PubMed ID: 8608840
    [No Abstract]   [Full Text] [Related]  

  • 5. Comparing two modalities of screening for prostate cancer: digital rectal examination + transrectal ultrasonography vs. prostate-specific antigen.
    Ciatto S; Bonardi R; Mazzotta A; Lombardi C; Santoni R; Cardini S; Zappa M
    Tumori; 1995; 81(4):225-9. PubMed ID: 8540115
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Update on urology--prostatic cancer. 2--Diagnosis and assessment of prostatic cancer.
    Ravery V; Boccon-Gibod L
    Eur J Surg Oncol; 1995 Aug; 21(4):419-21. PubMed ID: 7545138
    [No Abstract]   [Full Text] [Related]  

  • 7. Prostate-specific antigen coordinated with digital rectal examination and transrectal ultrasonography in the detection of prostate cancer.
    Cooner WH
    World J Urol; 1993; 11(4):214-7. PubMed ID: 7508786
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prostate cancer screening within a prostate specific antigen range of 3 to 3.9 ng./ml.: a comparison of digital rectal examination and free prostate specific antigen as supplemental screening tests.
    Mäkinen T; Tammela TL; Hakama M; Stenman UH; Rannikko S; Aro J; Juusela H; Määttänen L; Auvinen A
    J Urol; 2001 Oct; 166(4):1339-42. PubMed ID: 11547069
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Diagnosis and overdiagnosis of prostate cancer: a personal view.
    Tam PC
    Hong Kong Med J; 2012 Dec; 18(6):456-8. PubMed ID: 23223644
    [No Abstract]   [Full Text] [Related]  

  • 10. [Diagnostic accuracy of transrectal ultrasonography for screening of prostatic cancer].
    Watanabe M; Saitoh M; Watanabe H
    Hinyokika Kiyo; 1996 Oct; 42(10):763-6. PubMed ID: 8951472
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Diagnosis of prostate cancer].
    Kaprin AD; Anan'ev AP; Amosov FR; Gafanov RA
    Vopr Onkol; 1999; 45(1):20-5. PubMed ID: 10941360
    [No Abstract]   [Full Text] [Related]  

  • 12. The value of screening tests in the detection of prostate cancer. Part II: Retrospective analysis of free/total prostate-specific analysis ratio, age-specific reference ranges, and PSA density.
    Bangma CH; Kranse R; Blijenberg BG; Schröder FH
    Urology; 1995 Dec; 46(6):779-84. PubMed ID: 7502415
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Diagnostic significance of prostate specific antigen and the development of a mass screening system for prostate cancer.
    Imai K; Ichinose Y; Kubota Y; Yamanaka H; Sato J
    J Urol; 1995 Sep; 154(3):1085-9. PubMed ID: 7543604
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Early detection of prostate cancer with PSA: the Washington University experience.
    Smith DS
    Can J Oncol; 1994 Nov; 4 Suppl 1():57-62. PubMed ID: 8853491
    [No Abstract]   [Full Text] [Related]  

  • 15. Screening for prostate cancer.
    Waldman AR; Osborne DM
    Oncol Nurs Forum; 1994 Oct; 21(9):1513-7. PubMed ID: 7529409
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [An analysis of preliminary results in screening for prostatic cancer].
    Matveev BP; Bukharkin BV; Komarova LE; Kadagidze ZG; Sholokhov VN; Sokolov AV; Smirnov AV; Cheban NL; Perederiĭ NV; Lepédatu PI
    Urol Nefrol (Mosk); 1998; (2):30-4. PubMed ID: 9577701
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prostate-specific antigen (PSA) value change after antibacterial therapy of prostate inflammation, as a diagnostic method for prostate cancer screening in cases of PSA value within 4-10 ng/ml and nonsuspicious results of digital rectal examination.
    Karazanashvili G; Managadze L
    Eur Urol; 2001 May; 39(5):538-43. PubMed ID: 11464034
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Screening for prostatic carcinoma.
    Hinman F
    J Urol; 1991 Jan; 145(1):126-9; discussion 129-30. PubMed ID: 1701495
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Screening for prostate cancer: enthusiasm.
    Catalona WJ
    Urology; 1993 Aug; 42(2):113-5. PubMed ID: 7690167
    [No Abstract]   [Full Text] [Related]  

  • 20. DRE-PSA data revisited: PSA sampling should precede DREs.
    Douville P; Cembrowski G
    Arch Intern Med; 1996 Jun; 156(12):1352-3. PubMed ID: 8651846
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.